Clinical Trial Update: A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity. [Phase 1]

View source ↗

Summary

Pfizer is conducting a Phase 1 pharmacokinetic study to learn how PF-08653944 is absorbed into the bloodstream in adults with overweight or obesity.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity
• Overweight

Drugs mentioned

• PF-08653944

Snippet

Sponsor: Pfizer | Conditions: Overweight, Obesity | Phase 1 | Status: RECRUITING